Estimating the Economic Consequences of an Increased Medication Adherence Due to a Potential Improvement in the Inhaler Technique With Spiromax® Compared With Turbuhaler® In Patients With Moderate-To-Severe Chronic Obstructive Pulmonary Disease in Spain
ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s125301
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Informa UK Limited